AstraZeneca

In the last 48 hours

Durvalumab Regimen Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Pharmacy Times17:14

Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments |… PR Newswire (Press Release)22:52 15-May-25

Executives On The Move: Pathos Procures CEO From AstraZeneca, New CEO For TME Pharma, And More Scrip Pharma Intelligence15:09

Aptamer announces new data at ASGCT European Pharmaceutical Manufacturer15:06

York firm reports progress with 'multi-billion dollar' liver treatment opportunities York Press10:59 15-May-25

Alteogen’s breakout Q1 overshadowed by US scrutiny of subcutaneous drug combos Korea Biomedical Review05:12 15-May-25

AZ's needle-free, intranasal flu vaccine wins Korean approval Korea Biomedical Review06:25 15-May-25

view more headlines

In the last 14 days

GSK and Astrazeneca shares slump as Trump vows drug price cut City AM09:15 12-May-25

Why did the AstraZeneca share price just fall, and what should we do? Motley Fool (UK)12:55 12-May-25

AstraZeneca and GSK in the firing line as Trump targets big pharma: Alex Brummer This is Money22:08 12-May-25

AstraZeneca invests €600 million in new hub in Lisbon Portugal Resident12:02 8-May-25

How Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89% Zacks16:01 9-May-25

GSK, AstraZeneca slide after FDA unveils new vaccine lead ShareCast11:36 7-May-25

21 analysts advised buy AstraZeneca shares in January – see what £10k invested then is worth now Motley Fool (UK)08:04 13-May-25

After AstraZeneca tells investors to stay away, Aston Martin and BAE Systems move annual general meetings online This is Money21:55 3-May-25

'World first': AstraZeneca granted UK license for 'near-zero' emission inhaler medicine BusinessGreen11:30 12-May-25

Does the GSK or AstraZeneca share price currently offer the best value? Motley Fool (UK)06:21 8-May-25

AstraZeneca gets UK approval for Trixeo with eco-friendly propellant London South East09:17 12-May-25

World-first approval supports AstraZeneca’s sustainability goals European Pharmaceutical Review00:17 13-May-25

Investors await Fed decision, GSK and AstraZeneca weigh on F... IG11:04 7-May-25

UK approves AZ inhaler with 'greener' propellant pharmaphorum13:17 12-May-25

AstraZeneca’s Imfinzi combo shows DFS improvement in bladder cancer trial Clinical Trials Arena11:40 12-May-25

AstraZeneca and GSK slide as Trump and RFK appoint new FDA vaccine chief Proactive Investors (UK)11:02 7-May-25

AstraZeneca’s Enhertu Shows Promise in Early-Stage Breast Cancer Trial TipRanks07:34 7-May-25

News Medical: Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment The ME Association (Press Release)16:42 6-May-25

Intertek agrees acquisition of Tesis, AstraZeneca's Calquence gets fresh Europe approval ShareCast08:07 6-May-25

Inside The Cell Therapeutics Plant Kicking Off AstraZeneca's $3.5B U.S. Push Bisnow07:58 6-May-25

AZ plots wider Imfinzi use in bladder cancer after trial win pharmaphorum11:32 9-May-25

AstraZeneca Loses Bid to Revive Drug Price Suit at Third Circuit Bloomberg Law15:40 8-May-25

AstraZeneca’s Imfinzi delays bladder cancer return in high-risk patients Proactive Investors (UK)07:59 9-May-25

Tempus AI Stock: Time to Double Down or Cut and Run? Entrepreneur Magazine13:10 8-May-25

EU Approves AstraZeneca Mantle Cell Lymphoma Treatment PharmTech.com17:03 9-May-25

view more headlines

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.